{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670320549259520.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1038/ncpneph0575"}},{"identifier":{"@type":"URI","@value":"http://www.nature.com/articles/ncpneph0575.pdf"}},{"identifier":{"@type":"URI","@value":"http://www.nature.com/articles/ncpneph0575"}}],"dc:title":[{"@value":"The incidence and implications of aldosterone breakthrough"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383670320549259520","@type":"Researcher","foaf:name":[{"@value":"Andrew S Bomback"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320549259521","@type":"Researcher","foaf:name":[{"@value":"Philip J Klemmer"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"17458323"},{"@type":"EISSN","@value":"17458331"},{"@type":"PISSN","@value":"https://id.crossref.org/issn/17458323"}],"prism:publicationName":[{"@value":"Nature Clinical Practice Nephrology"}],"dc:publisher":[{"@value":"Springer Science and Business Media LLC"}],"prism:publicationDate":"2007-09","prism:volume":"3","prism:number":"9","prism:startingPage":"486","prism:endingPage":"492"},"reviewed":"false","dc:rights":["http://www.springer.com/tdm"],"url":[{"@id":"http://www.nature.com/articles/ncpneph0575.pdf"},{"@id":"http://www.nature.com/articles/ncpneph0575"}],"createdAt":"2007-08-24","modifiedAt":"2023-05-18","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004233405541760","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Mineralocorticoid receptor activation in obesity hypertension"}]},{"@id":"https://cir.nii.ac.jp/crid/1360018984922946688","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Insights into drug development with quantitative systems pharmacology: A prospective case study of uncovering hyperkalemia risk in diabetic nephropathy with virtual clinical trials"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285709651314432","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"ARB protects podocytes from HIV-1 nephropathy independently of podocyte AT1"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285714188811008","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The velocity of home blood pressure reduction in response to low-dose eplerenone combined with other antihypertensive drugs determined by exponential decay function analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306906099935488","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Factors influencing the efficacy and safety of esaxerenone in hypertensive patients: a pooled analysis of five clinical studies on different comorbidities"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565167634493184","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Excess aldosterone is a critical danger signal for inflammasome activation in the development of renal fibrosis in mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565168684878848","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Renal Dysfunction Induced by Kidney-Specific Gene Deletion of\n            <i>Hsd11b2</i>\n            as a Primary Cause of Salt-Dependent Hypertension"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567182277059456","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"An in vivo role of bone morphogenetic protein-6 in aldosterone production by rat adrenal gland"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567184173270656","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Olmesartan combined with renal denervation reduces blood pressure in association with sympatho-inhibitory and aldosterone-reducing effects in hypertensive mice with chronic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567186750836224","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567188091582464","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Midkine Regulates BP through Cytochrome P450–Derived Eicosanoids"}]},{"@id":"https://cir.nii.ac.jp/crid/1360568465821111936","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Reduction in urinary angiotensinogen levels and improvement of proteinuria by renin–angiotensin system blockade in pediatric chronic kidney disease patients with very low birth weight"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584340531037952","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Sacubitril/valsartan ameliorates renal tubulointerstitial injury through increasing renal plasma flow in a mouse model of type 2 diabetes with aldosterone excess"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846641714903040","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Mineralocorticoid Receptor-Associated Hypertension and Its Organ Damage: Clinical Relevance for Resistant Hypertension"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204274705408","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Revisiting the therapeutic concept of a mineralocorticoid receptor antagonist — focusing on resistant hypertension and chronic renal failure"},{"@language":"ja","@value":"ミネラロコルチコイド受容体拮抗薬の新たな治療コンセプト—治療抵抗性高血圧および慢性腎臓病を中心に—"},{"@value":"ミネラロコルチコイド受容体拮抗薬の新たな治療コンセプト : 治療抵抗性高血圧および慢性腎臓病を中心に"},{"@language":"ja-Kana","@value":"ミネラロコルチコイド ジュヨウタイ キッコウヤク ノ アラタ ナ チリョウ コンセプト : チリョウ テイコウセイ コウケツアツ オヨビ マンセイ ジンゾウビョウ オ チュウシン ニ"},{"@value":"Revisiting the therapeutic concept of a mineralocorticoid receptor antagonist ^|^mdash; focusing on resistant hypertension and chronic renal failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205179600512","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"New Approaches to Blockade of the Renin-Angiotensin-Aldosterone System: Mineralocorticoid-Receptor Blockers Exert Antihypertensive and Renoprotective Effects Independently of the Renin-Angiotensin System"},{"@value":"Mineralocorticoid-receptor blockers exert antihypertensive and renoprotective effects independently of the renin-angiotensin system"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282763117534336","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Renin Activity as a Key Predictor of Major Adverse Cardiac Events"},{"@value":"Plasma Renin Activity Is an Independent Prognosticator in Patients With Myocardial Infarction"}]},{"@id":"https://cir.nii.ac.jp/crid/1390854064999823872","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Rationale and Design of the Efficacy and Safety of Esaxerenone in Hypertensive Patients With Left Ventricular Hypertrophy (ESES-LVH) Study　― Protocol for a Multicenter, Open-Label, Exploratory Interventional Study ―"}]},{"@id":"https://cir.nii.ac.jp/crid/1391693801395317632","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effects of dapagliflozin on renin-angiotensin-aldosterone system under renin-angiotensin system inhibitor administration"}]},{"@id":"https://cir.nii.ac.jp/crid/2051996266980601600","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1038/ncpneph0575"},{"@type":"CROSSREF","@value":"10.1007/s10157-010-0298-8_references_DOI_Uz9zWvF066l3sCSAWe0Guc5bY6H"},{"@type":"CROSSREF","@value":"10.1038/hr.2009.86_references_DOI_Uz9zWvF066l3sCSAWe0Guc5bY6H"},{"@type":"CROSSREF","@value":"10.1254/fpj.139.241_references_DOI_Uz9zWvF066l3sCSAWe0Guc5bY6H"},{"@type":"CROSSREF","@value":"10.1016/j.dmpk.2024.101019_references_DOI_Uz9zWvF066l3sCSAWe0Guc5bY6H"},{"@type":"CROSSREF","@value":"10.1093/ndt/gfs033_references_DOI_Uz9zWvF066l3sCSAWe0Guc5bY6H"},{"@type":"CROSSREF","@value":"10.3109/10641963.2014.892117_references_DOI_Uz9zWvF066l3sCSAWe0Guc5bY6H"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-18-1195_references_DOI_Uz9zWvF066l3sCSAWe0Guc5bY6H"},{"@type":"CROSSREF","@value":"10.1038/s41440-024-01818-0_references_DOI_Uz9zWvF066l3sCSAWe0Guc5bY6H"},{"@type":"CROSSREF","@value":"10.1096/fj.15-271734_references_DOI_Uz9zWvF066l3sCSAWe0Guc5bY6H"},{"@type":"CROSSREF","@value":"10.1161/hypertensionaha.116.08966_references_DOI_Uz9zWvF066l3sCSAWe0Guc5bY6H"},{"@type":"CROSSREF","@value":"10.1080/10641963.2018.1465075_references_DOI_Uz9zWvF066l3sCSAWe0Guc5bY6H"},{"@type":"CROSSREF","@value":"10.1186/1755-1536-4-25_references_DOI_Uz9zWvF066l3sCSAWe0Guc5bY6H"},{"@type":"CROSSREF","@value":"10.1681/asn.2013121259_references_DOI_Uz9zWvF066l3sCSAWe0Guc5bY6H"},{"@type":"CROSSREF","@value":"10.1007/s00467-020-04520-8_references_DOI_Uz9zWvF066l3sCSAWe0Guc5bY6H"},{"@type":"CROSSREF","@value":"10.1093/ndt/gfad098_references_DOI_Uz9zWvF066l3sCSAWe0Guc5bY6H"},{"@type":"CROSSREF","@value":"10.1038/ajh.2011.245_references_DOI_Uz9zWvF066l3sCSAWe0Guc5bY6H"},{"@type":"CROSSREF","@value":"10.1254/jphs.10r06fm_references_DOI_Uz9zWvF066l3sCSAWe0Guc5bY6H"},{"@type":"CROSSREF","@value":"10.1253/circrep.cr-21-0122_references_DOI_Uz9zWvF066l3sCSAWe0Guc5bY6H"},{"@type":"CROSSREF","@value":"10.1507/endocrj.ej20-0222_references_DOI_Uz9zWvF066l3sCSAWe0Guc5bY6H"},{"@type":"CROSSREF","@value":"10.1016/j.jsbmb.2012.04.004_references_DOI_Uz9zWvF066l3sCSAWe0Guc5bY6H"}]}